Vanguard Group’s Greenwich LifeSciences GLSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.44M | Sell |
|
|||||
|
2025
Q1 | $2.58M | Sell |
|
|||||
|
2024
Q4 | $3.09M | Buy |
|
|||||
|
2024
Q3 | $3.93M | Buy |
|
|||||
|
2024
Q2 | $4.63M | Buy |
|
|||||
|
2024
Q1 | $4.45M | Buy |
|
|||||
|
2023
Q4 | $2.33M | Buy |
|
|||||
|
2023
Q3 | $1.94M | Sell |
|
|||||
|
2023
Q2 | $2.72M | Sell |
|
|||||
|
2023
Q1 | $4.86M | Buy |
|
|||||
|
2022
Q4 | $5.24M | Buy |
|
|||||
|
2022
Q3 | $3.13M | Sell |
|
|||||
|
2022
Q2 | $3M | Sell |
|
|||||
|
2022
Q1 | $7.36M | Buy |
|
|||||
|
2021
Q4 | $3.65M | Buy |
|
|||||
|
2021
Q3 | $5.83M | Buy |
|
|||||
|
2021
Q2 | $5.46M | Buy |
|
|||||
|
2021
Q1 | $3.62M | Buy |
|
|||||
|
2020
Q4 | $412K | Buy |
|